Hypertriglyceridemia induced acute pancreatitis (HTGP) was associated with increased risk of local complications, recurrent acute pancreatitis (AP), the frequency of other complications, and its high mortality as compared to other causes. Determining the factors associated with the severity of HTGP was necessary and important in the management of patients with AP.This study aims to examine the clinical and biochemical characteristics of HTGP patients, and to determine the factors associated with the severity of HTGP according to the revised Atlanta classification.This retrospective and prospective study enrolled 157 HTGP patients from January 2016 to May 2019 at Cho Ray Hospital who had serum TG levels measured within the first 48 hours of admittance with a TG concentration ≥ 1000 mg/dL and excluded other causes. The clinical features and outcomes of patients with HTGP were determined in terms of demographics, clinical symptoms, laboratory data, system complications, local complications, disease severity, and length of hospital stay. The primary outcome was the severity of HTGP as based according to the revised Atlanta classification. We evaluated the relationship between general information, clinical factors and laboratory data in the study population.There were 157 HTGP patients participated in this study. Patients with HTGP had evidence of obese or overweight range (61.2%), history of diabetes mellitus (32.5%) or undiagnosed diabetes (28.0%), history of AP (35.7%), alcohol use (23.6%), hypertension (15.9%), dyslipidemia (13.4%). The patients had typical symptoms of AP, including pancreatic abdominal pain (upper abdominal pain) (93%), nausea/vomiting (80.9%), fever (59.2%), distension abdomen (84.7%), and resistance of abdominal wall (24.8%). The severity of HTGP was significantly associated with fever, altered mental status, rapid pulse, and hypotension (P < .05). Patients with severe HTGP had significantly more pancreatic necrosis, higher values of Blood urea nitrogen and creatinine, longer prothrombin time and activated partial thromboplastin time on admission and higher CRP48 than not severe HTGP (P < .05).The severity of HTGP was significantly related to clinical factors including fever, altered mental status, rapid pulse, hypotension, and pancreatic necrosis. The value of Blood urea nitrogen, creatinine, prothrombin time, and activated partial thromboplastin time at admission is higher and longer in the severe AP group with P < .05.

Background: Hepatitis B virus infection continues to be a public health problem in developing countries. This study aimed to assess the percentage of hepatitis B virus infection and related factors among adult population in Tra Vinh Province, Vietnam 2022. Methods: The study applied the cross-sectional descriptive design with the combination of structured interview and serological blood tests, from September 1, 2021, to June 1, 2022. Results: There were 1,289 respondents in the study. Overall, the percentage of sample positive reaction with HBsAg were 7.68% (99 peoples). Most of the people did not likely have relatives with a family history of hepatitis B virus infection, the proportion of people who had household family members who had hepatitis B, hepatocellular carcinoma, and cirrhosis was 1.24%, 0.93%, and 2.48% respectively. People who did not preventive vaccination for hepatitis B virus had higher rates of HBsAg (+) than people get preventive vaccination, with p=0.005. However, in other medical practice, the rate of HBsAg was non-significance, such as blood transfusion, surgery, dental treatment, injecting medications, and injected skin boils. The percentage of hepatitis B virus infection in the study was not significantly associated with hepatitis B prevention practices in daily life, including acupuncture, sharing shavers, sharing toothbrushes, sharing nail tools, and spraying tattoo. Conclusions: The percentage of hepatitis B virus infection in Tra Vinh province was 7.68%. There was a statistically significant relationship between the incidence of hepatitis B with preventive vaccination for the hepatitis B virus.